Asia Pharma R&D Leaders Summit 2017
March. 21 ( Tuesday ) to March 22 ( Wednesday ), 2017
Slide 1

About APRDL 2017

The Pharma and Biotech sectors are at a pivotal point in their evolution. Pharmaceutical companies are likely to continue to increase the percentage of their R&D work that is outsourced in Asia. This trend will continue to be driven by the pursuit of Open Innovation in University-Industrial Partnership, Improving R&D cost efficiency as well as effectiveness. Beyond generating one-off savings, the emphasis will move to streamlining the outsourcing operating model, risk management, complexity management and lean process improvement. Doing more R&D with less and smartly.....
Speaker Faculty
Soren Tullin
Corporate Vice President for Discovery Biology & Technology
Novo Nordisk A/S
Tobias Gabriel
Global Head of External Drug Discovery at Global Discovery Chemistry
Novartis Institutes for BioMedical Research
Binhui (Ben) Ni
AVP, Head, External Innovation &Partnering, Strategy and Business Development, Asia Pacific
Mike Dethick
Managing Director
R&D-Based Pharmaceutical Association Committee
Asia Pharma R&D Leaders Summit 2017  |  Telephone: +86 21 6172 6970  |  E-mail:
© 2016 Asia Pharma R&D Leaders Summit 2017- All rights reserved